# Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

> **NCT00994370** · — · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 36 (actual)

## Conditions studied

- Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00994370
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994370, "Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00994370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*